All COVID vaccines do not prevent infection and are primarily disease-modifying, said Dr Balram Bhargava, director general, Indian Council of Medical Research on Thursday.
The Rhesus macaque monkeys, used worldwide in medical research, are believed to be the best non-human primates for such studies.
Officials said several witnesses were heard on the impact of the pandemic. They added that this was the longest meeting of the panel without a break so far.
ICMR Director General said some studies have suggested that antibodies last for three months while some others said they may last in the body for up to five months also.
He asserted that all efforts are on to contain the spread of the virus in Kerala.
The ICMR's statement came against the backdrop of the World Health Organization (WHO) suspending the testing of the drug in COVID-19 patients temporarily in its global study following safety concerns.
Besides MPs, parliament staff and media personnel, among other entrants to the building, will also be required to undergo the test for the coronavirus.
Here is an explainer on the functioning of the seven-year-old body.
I suggest we build a Vigyan Mandir (Temple of Science) with the ambience of a place of worship, so that it becomes a destination for pilgrims. We should embed on its walls bronze plaques describing each scientist mentioned here along with about a dozen of our ancient mathematicians, recommends Professor Kalyan Singhal, historian of science and technology.
Indian Council of Medical Research had also recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases and also the asymptomatic household contacts of the lab-confirmed cases.
Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.
Bharat Biotech's Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.
"We are very worried about the rise in cases in Maharashtra. Don't take this virus for granted. It can come up unexpectedly. If we have to remain free of this virus, COVID-appropriate behaviour, containment strategy as well as vaccination has to be brought in," Paul said.
A 22-year-old man, who recently returned to Kerala from the UAE, allegedly died due to monkeypox on Saturday.
The 'antisera' has been developed by the ICMR in collaboration with a Hyderabad-based bio-pharmaceutical firm. "With Biological E Limited we have developed an horse 'antisera' and we have just got clearance for conducting clinical trials for that," ICMR Director General Dr Balram Bhargava said at press briefing.
Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
In a letter to the state chief secretaries on Monday, ICMR Director General (D-G) Dr Balram Bhargava said the COVID-19 diagnostic supplies are stabilising because of the indigenous production of the kits.
Prime Minister Modi has said India's vaccine production and delivery capacity will be used for the benefit of all humanity to fight the COVID-19 pandemic. He said last week India was ready to do everything possible for a healthy planet.
Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.
Over 21 per cent of the population, aged 10 years and above, showed evidence of past exposure to COVID-19 in the Indian Council of Medical Research's latest national serosurvey, the government said on Thursday, noting that a large proportion of people are still vulnerable to the infection.
The joint secretary also said a high-level task force to work on frontiers of science related to vaccines and drug testing was formed on Sunday.
Union health secretary Rajesh Bhushan said 50 districts account for 66 per cent of the total caseload and the COVID-19 case fatality rate has progressively declined to 2.10 per cent, the lowest since the first lockdown was imposed on March 25.
The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now, official sources said on Tuesday.
A day after the WHO declared emergency over the "explosive" spread of the mosquito-borne Zika virus, the Centre on Tuesday issued detailed guidelines for combating the disease, including a travel advisory that asks pregnant women to either defer or cancel their travel to the affected areas.
The civil aviation ministry had last week suspended all flights between the European country and India from December 23 to December 31 as a mutated variant of the coronavirus was detected there.
We need to give a booster shot to all our frontline workers first as if they fall victim to Omicron, the health system will collapse, points out Ramesh Menon.
COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India
The death toll due to the disease has climbed to 4,43,213, with 339 daily fatalities being recorded, the data updated at 8 am showed.
'Please don't read something which is not there in DG, ICMR's letter. The intent of the letter is only to expedite duly approved clinical trials without compromising on security and safety concerns'
A trial has shown that plasma therapy does not reduce mortality or prevent progression of COVID-19.
Thirty districts in the country, including 13 in Kerala, eight in Mizoram, four in Meghalaya, three each in Manipur and Arunachal Pradesh, two in Sikkim and one in Meghalaya are reporting a weekly positivity rate of over 10 per cent.
'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'
The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.
The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care.
'Our client is suffering due to the ill-effects of the vaccine. He has to be compensated for his suffering. Further, a detailed investigation has to be done on the Covishield vaccine and its side-effects,' says the volunteer's advocate.
He urged people not to panic and clarified that there was no change in the guidelines for international air travel so far.
One in 15 individuals aged 10 years and above were estimated to be exposed to SARS- CoV2 by August 2020, ICMR's 2nd sero-survey said.
The remarks come amid suspected cases of COVID-19 reinfection being reported from abroad and from Indian states like Telangana, Karnataka, Gujarat, Punjab and Maharashtra.
'We have the technical expertise, and international collaborations. We also have robust real-time data. We are a university of pandemic management. If the ministry neglects the role of NCDC, it is the loss of the country'
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances